Lubripharm™ SSF
Our SSF excipients are backed by global regulatory audit approvals and designed to outperform traditional magnesium stearate. From consistent quality to patient-centric performance, we help manufacturers deliver safer, faster, and more effective medicines across dosage forms and therapeutic areas.
Lubripharm™ SSF
Certified, Patient-Focused, and Ready for Next-Gen Pharma
SSF excipients are engineered to meet the evolving needs of modern pharmaceutical manufacturing. With proven regulatory certifications, superior performance over traditional lubricants, and versatility across dosage forms and APIs, SSF helps manufacturers deliver high-quality, patient-friendly medicines with greater efficiency and reliability.

✅ Regulatory Confidence – Produced in certified facilities with global audit approvals
✅ Superior to Magnesium Stearate – Overcomes challenges with unstable APIs, over-blending sensitivity, dissolution time, and hardness
✅ Outperforms Competition – Better tablet performance, controlled particle size & surface area, and lower ejection force than JRS/IFF
✅ Patient-Centric Formulations – Ideal for chewables, ODTs, sublingual, and swallow tablets with faster disintegration and better mouthfeel
✅ Designed for Continuous Manufacturing – Delivers reliable, consistent performance across extended production runs
✅ Therapeutic Application Versatility – Compatible with APIs for diabetes, cardiovascular, oncology, neurology, GLP-1, and other next-gen therapies
✅ Dosage Form Flexibility – Suitable for sublingual, chewable, and immediate/modified release tablets
✅ Market-Ready Solutions – Flexible packaging options, closer-to-market support, and cost-effective performance
Contact our Experts Today
Learn how SPI Pharma and Q-Vant can enhance access to Saponin based Adjuvants and enhance your vaccine development. Contact us to discuss your developments with our experts